[1] |
XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue.
285 cases of adverse drug reaction related to new antineoplastic drugs
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203.
|
[2] |
ZHANG Yuqi, XU Xinyi, ZHU Lan, ZHU Yan.
Comparison standard terminology for pharmaceutical dose forms
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(8): 904-910.
|
[3] |
YU Yuehua, ZHAO Yan, LU Tiangong, SUN Zhenxiao.
Screening and in vitro study of traditional Chinese medicines against lung adenocarcinoma based on EGFR
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 735-741.
|
[4] |
ZHANG Lei, LYU Jian, XIE Yanming.
Efficacy and safety of Houpupaiqi Mixture in the treatment of postoperative lieus: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 799-806.
|
[5] |
QIN Guilan, ZHOU Muzi, JI Zhaoshuai, MAO Qiantai, AI Chao.
One case of acute constipation induced by semaglutide injection
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(7): 833-835.
|
[6] |
CHENG Fengjingming, LYU Jian, XIE Yanming.
Efficacy and safety of compound salvia miltiorrhiza spray/aerosol for angina pectoris due to coronary artery disease: a Meta analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(5): 536-543.
|
[7] |
SU Xinxin, LYU Jian, XIE Yanming.
Efficacy and safety of Toutongning capsules in the treatment of chronic headache: a Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 433-440.
|
[8] |
CAO Lin, RAN Zheng, HOU Qiang, QIU Zuocheng, YANG Jianhua.
Chemical composition of Huatie compound and prediction of potential mechanism for prevention and treatment of hyperplasia of mammary glands
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(10): 1113-1120.
|
[9] |
WEI Hongtao, SHEN Su, LI Dandan, LIAO Yin.
Pareto chart analysis of 705 problematic prescriptions in neurology
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 900-903.
|
[10] |
MENG Kangkang, WANG Chunting, XIONG Weiyi.
Safety of propranolol tablets for infantile hemangioma
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 749-751.
|
[11] |
LI Yu, FAN Huihui, FENG Xiaojun, ZHANG Yonghuang, CHEN Qin, WANG Yunhong, CHEN Chuantao, ZHANG Lei, SHI Tianlu.
Association between ABCB1 C3435T polymorphisms and methotrexate-induced toxicity in childhood acute lymphoblastic leukemia: Meta analysis
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(4): 421-425.
|
[12] |
WANG Xin, ZHANG Jie, ZHANG Ming, ZHANG Nan, AI Chao.
One case of erythema multiforme drug eruption induced by acetylcysteine capsule combined with fudosteine tablets
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(2): 217-218.
|
[13] |
LIU Bo, WANG Xue, GUAN Shaochen, AN Moran, MU Yajie, YU Haixia, LI Yonglin, ZHANG Yatong.
Adverse Reactions of Lianhua Qingwen Capsules/Granules: A Systematic Review and Meta-analysis
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(9): 864-868.
|
[14] |
YANG Xiaowen, WANG Xiaoxing.
One Case of Hyperkalemia Induced by Concomitant Use of Cyclosporine and Other Drugs
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(12): 1192-1195.
|
[15] |
HUANG Yuan, WANG Chenggang, WU Shifu, WANG Ling, TIAN Yuejie, WU Chen, WANG Xiaojun.
Drug Abuse Monitoring Models in Medical Institutions in China
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 607-612.
|